Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PHARMACOSMOS A/S - Group

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 0.3% 0.3% 29.3% 29.0% 29.0% 29.0% 29.0%   Credit score (0-100)   0 100 100 2 3 2 1 1   Credit rating   N/A AAA AAA C B B B B   Credit limit (kDKK)   0.0 101,543.1 104,628.6 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Net sales   0 616,747 613,893 0 0 0 0 0   Gross profit   0.0 388,350 370,179 0.0 0.0 0.0 0.0 0.0   EBITDA   0.0 195,539 127,079 0.0 0.0 0.0 0.0 0.0   EBIT   0.0 195,539 127,079 0.0 0.0 0.0 0.0 0.0   Pre-tax profit (PTP)   0.0 206,361.0 91,357.0 0.0 0.0 0.0 0.0 0.0   Net earnings   0.0 158,715.0 69,125.0 0.0 0.0 0.0 0.0 0.0   Pre-tax profit without non-rec. items   0.0 206,361 91,357 0.0 0.0 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Tangible assets total   0.0 245,624 211,714 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 656,757 720,762 0.0 0.0 0.0 0.0 0.0   Interest-bearing liabilities   0.0 126,801 266,663 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0.0 983,443 1,184,275 0.0 0.0 0.0 0.0 0.0   Net Debt   0.0 -261,274 -114,164 0.0 0.0 0.0 0.0 0.0     See the entire balance sheet 1000.0 Volume  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Net sales   0 616,747 613,893 0 0 0 0 0   Net sales growth   0.0% 0.0% -0.5% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 388,350 370,179 0.0 0.0 0.0 0.0 0.0   Gross profit growth   0.0% 0.0% -4.7% -100.0% 0.0% 0.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 983,443 1,184,275 0 0 0 0 0   Balance sheet change%   0.0% 0.0% 20.4% -100.0% 0.0% 0.0% 0.0% 0.0%   Added value   0.0 195,539.0 127,079.0 0.0 0.0 0.0 0.0 0.0   Added value %   0.0% 31.7% 20.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 399,201 193,748 -592,949 0 0 0 0   Net sales trend   0.0 0.0 -1.0 -2.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 1.0 2.0 0.0 0.0 0.0 0.0 0.0   1000.0 Profitability  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A EBITDA %   0.0% 31.7% 20.7% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 31.7% 20.7% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 50.4% 34.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net Earnings %   0.0% 25.7% 11.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 25.7% 11.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 33.5% 14.9% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 21.7% 12.3% 0.0% 0.0% 0.0% 0.0% 0.0%   ROI %   0.0% 25.8% 14.1% 0.0% 0.0% 0.0% 0.0% 0.0%   ROE %   0.0% 24.2% 10.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Solidity  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Equity ratio %   0.0% 66.8% 60.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative indebtedness %   0.0% 45.9% 64.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% -17.0% 2.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -133.6% -89.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Gearing %   0.0% 19.3% 37.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 10.6% 21.1% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Quick Ratio   0.0 2.3 3.1 0.0 0.0 0.0 0.0 0.0   Current Ratio   0.0 2.7 3.7 0.0 0.0 0.0 0.0 0.0   Cash and cash equivalent   0.0 388,075.0 380,827.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Trade debtors turnover (days)   0.0 45.8 54.1 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 94.7% 96.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 364,697.0 430,953.0 0.0 0.0 0.0 0.0 0.0   Net working capital %   0.0% 59.1% 70.2% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2015 N/A 2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021e N/A 2022e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0